M/10/037 – Pfizer / King

Transaction details

The Competition Authority has cleared the proposed transaction whereby Pfizer Incorporated would acquire sole control of King Pharmaceuticals Incorporated.

Notification date Decision date
Friday October 29, 2010 Wednesday, November 24, 2010
Parties Involved Business activities
Pfizer Inc.

Pfizer is a global research-based biomedical and pharmaceutical company active in discovering, developing, manufacturing, marketing and selling innovative medicines for humans and animals.

King Pharmaceuticals Inc.

King is a pharmaceutical company that develops, manufactures and markets therapies and technologies primarily in speciality-driven markets including neuroscience, hospital and acute care medicines.

Economic sector Media merger
Animal health products in the State. No
Submissions from third parties due by:
Phase 1 Phase 2
Wednesday, November 10, 2010
Current status: Completed
Cleared (Phase 1)
Authorised Officer Assigned Contact Details
Ms. Elisa Ryan

Tel: 01-804 5446, email:er@tca.ie

Media enquiries: MKC Communications: 01 7038600

Return to Merger Notifications

Haven’t found what you’re looking for?